\ NASDAQ Morning Movers; (FURX), (IDIX), (MCBC), (VELT)
Company News: Page (1) of 1 - 01/28/13

NASDAQ Morning Movers; (FURX), (IDIX), (MCBC), (VELT)

January 28, 2013 --

NASDAQ Morning Movers; (FURX), (IDIX), (MCBC), (VELT)

Category: Investment

Visit: Furiex Pharmaceuticals Inc.

New York, New York - January 28, 2013 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors reports on the top percentage gainers on the NASDAQ for January 28th, 2013.

Furiex Pharmaceuticals Inc., (NASDAQ:FURX) trading at $31.68 rose by $10.44 or 49.15% on a volume of 515,572 shares, making to today's top "morning mover" on the NASDAQ.

Furiex Pharmaceuticals Inc. stocks rose the highest in more than two years after partner Takeda Pharmaceutical Co. won U.S. regulatory approval for a new diabetes treatment.

The FDA cleared Takeda and Furiex's alogliptin and two combinations of the treatment to use with diet and exercise for patients with Type 2 diabetes. Morrisville, North Carolina-based Furiex said in a statement that it will receive a $25 million payment as a result of the approval as well as royalties based on U.S. sales.

Idenix Pharmaceuticals Inc., (NASDAQ:IDIX) trading at $5.26 gained $0.53 or 11.21% on a volume of 1,972,934 shares.

Idenix Pharmaceuticals, Inc. today announced a non-exclusive collaboration with Janssen Pharmaceuticals, Inc. for the clinical development of all-oral direct-acting antiviral (DAA) HCV combination therapies. The collaboration will evaluate combinations including IDX719, Idenix's once-daily pan-genotypic NS5A inhibitor, simeprevir (TMC435), a once-daily protease inhibitor jointly developed by Janssen and Medivir AB, and TMC647055, a once-daily non-nucleoside polymerase inhibitor, boosted with low dose ritonavir, being developed by Janssen.

Macatawa Bank Corp., (NASDAQ:MCBC) trading at $4 rose by $ 0.37 or 10.19% on a volume of 182,345 shares.

Velti Plc (NASDAQ:VELT) trading at $5.45 gained $0.42 or 8.35% on a volume of 984,169 shares.

Investorideas.com Newswire



About InvestorIdeas.com:

InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com

Sign up for the free investor news and stock alerts at Investorideas.com


Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more¯¯¯


Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.

BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

800-665-0411 - Source - www.Investorideas.com

Page: 1
Related Keywords:Sales,Advertising,Sales & Marketing,Internet,Sales,Sales,USA, Inc.,Science,Environmental Technology,Green Technology,Medical,Biology,

Source:Copyright (c) InvestorIdeas. All Rights Reserved

Our Privacy Policy --- @ Copyright, 2017 Digital Media Online, All Rights Reserved